New insights into adaptive enrichment designs
From MaRDI portal
Publication:6056988
DOI10.1007/S00362-023-01433-0MaRDI QIDQ6056988
Maroussa Zagoraiou, Alessandro Baldi Antognini, Rosamarie Frieri
Publication date: 4 October 2023
Published in: Statistical Papers (Search for Journal in Brave)
personalized medicinesubgroup identificationstratified medicinepredictive biomarkercontinuous biomarker
Cites Work
- Unnamed Item
- Unnamed Item
- Optimal designs for testing the efficacy of heterogeneous experimental groups
- Inference for a two-stage enrichment design
- Most powerful test sequences with early stopping options
- Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker
- Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment
- On closed testing procedures with special reference to ordered analysis of variance
- Special study designs: early escape, enrichment, studies in non-responders
- Evaluation of Experiments with Adaptive Interim Analyses
- Optimal, Two-Stage, Adaptive Enrichment Designs for Randomized Trials, using Sparse Linear Programming
- Adaptive patient enrichment designs in therapeutic trials
- Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R
- Adaptive enrichment designs with a continuous biomarker
- Discussion on “Adaptive enrichment designs with a continuous biomarker” by Nigel Stallard
This page was built for publication: New insights into adaptive enrichment designs